Cargando…
Post-operative residual disease and number of cycles of neoadjuvant chemotherapy in advanced epithelial ovarian carcinoma
BACKGROUND: The optimal number of neoadjuvant chemotherapy cycles in patients with advanced ovarian cancer is still disputed. OBJECTIVE: To evaluate the impact of the number of neoadjuvant chemotherapy cycles and role of optimal cytoreduction on the prognosis of patients with advanced ovarian cancer...
Autores principales: | Perrone, Anna Myriam, Coada, Camelia Alexandra, Ravegnini, Gloria, De Leo, Antonio, Damiano, Giuseppe, De Crescenzo, Eugenia, Tesei, Marco, Di Costanzo, Stella, Genovesi, Lucia, Rubino, Daniela, Zamagni, Claudio, De Iaco, Pierandrea |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10423511/ https://www.ncbi.nlm.nih.gov/pubmed/37429642 http://dx.doi.org/10.1136/ijgc-2022-004249 |
Ejemplares similares
-
Optimal number of neoadjuvant chemotherapy cycles prior to interval debulking surgery in advanced epithelial ovarian cancer: a systematic review and meta-analysis of progression-free survival and overall survival
por: Coada, Camelia Alexandra, et al.
Publicado: (2023) -
A Radiomic-Based Machine Learning Model Predicts Endometrial Cancer Recurrence Using Preoperative CT Radiomic Features: A Pilot Study
por: Coada, Camelia Alexandra, et al.
Publicado: (2023) -
Identification of miR-499a-5p as a Potential Novel Biomarker for Risk Stratification in Endometrial Cancer
por: Ravegnini, Gloria, et al.
Publicado: (2021) -
Classification Systems of Endometrial Cancer: A Comparative Study about Old and New
por: Coada, Camelia Alexandra, et al.
Publicado: (2021) -
Emerging Role of MicroRNAs in the Therapeutic Response in Cervical Cancer: A Systematic Review
por: Ravegnini, Gloria, et al.
Publicado: (2022)